Cmax of doxorubicin post infusion | 34 ± 5 | [μM] |
Doxorubicin at plasmapheresis onset | 72 ± 6% | [% of Cmax] |
Doxorubicin at plasmapheresis termination | 28 ± 9% | [% of Cmax] |
Elimination of total doxorubicin | 45 ±7% | [% of total doxorubicin dose] |
Elimination of doxorubicin in plasma | 62 ± 9% | [% of plasma doxorubicin at plasmapheresis initiation] |
Reduction in AUC | 50 ± 3% |